611 MYLAN (Methyldopa 250 mg)

Pill imprint 611 MYLAN has been identified as Methyldopa 250 mg.

Methyldopa is used in the treatment of high blood pressure; hypertensive emergency and belongs to the drug class antiadrenergic agents, centrally acting. Risk cannot be ruled out during pregnancy. Methyldopa 250 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for 611 MYLAN (Methyldopa 250 mg)

Methyldopa 250 mg 611 MYLAN
Methyldopa 250 mg 611 MYLAN
Methyldopa 250 mg 611 MYLAN Front
Methyldopa 250 mg 611 MYLAN Back
Methyldopa 250 mg 611 MYLAN
Methyldopa
Imprint:
611
MYLAN
Strength:
250 mg
Color:
Beige
Size:
11.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Antiadrenergic agents, centrally acting
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-0611
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
hypromelloses
magnesium stearate
microcrystalline cellulose
polydextrose
polyethylene glycol
sodium lauryl sulfate
titanium dioxide
triacetin
FD&C Yellow No. 6
FD&C Blue No. 2
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0200 UDL Laboratories Inc
54569-0508 A S Medication Solutions LLC (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web1)